UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000015187
Receipt number R000017107
Scientific Title Observational Cohort Study of Remission Maintenance Therapy in Japanese Patients with ANCA-associated Vasculitis and rapidly progressive glomerulonephritis
Date of disclosure of the study information 2014/09/17
Last modified on 2020/03/23 10:56:08

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Observational Cohort Study of Remission Maintenance Therapy in
Japanese Patients with ANCA-associated Vasculitis and rapidly progressive glomerulonephritis

Acronym

Co-RemIT-JAV-RPGN

Scientific Title

Observational Cohort Study of Remission Maintenance Therapy in
Japanese Patients with ANCA-associated Vasculitis and rapidly progressive glomerulonephritis

Scientific Title:Acronym

Co-RemIT-JAV-RPGN

Region

Japan


Condition

Condition

ANCA-associated vasculitis

Classification by specialty

Medicine in general Cardiology Pneumology
Nephrology Clinical immunology Dermatology
Oto-rhino-laryngology Radiology

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

To clarify the safety and efficacy of remission maintenance therapy in Japanese patients with ANCA-associated vasculitis.

Basic objectives2

Safety,Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Relapse

Key secondary outcomes

Renal survival
Survival


Base

Study type

Observational


Study design

Basic design


Randomization


Randomization unit


Blinding


Control


Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms


Purpose of intervention


Type of intervention


Interventions/Control_1


Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

Patients with ANCA-associated vasculitis registered in RemIT-JAV-RPGN study and under the remission maintenancy therapy

Key exclusion criteria

Patients without the agreement

Target sample size

170


Research contact person

Name of lead principal investigator

1st name Yoshihiro
Middle name
Last name Arimura

Organization

Kyorin University School of Medicine

Division name

First Department of Internal Medicine

Zip code

1818611

Address

6-20-2 Shinkawa, Mitaka-shi, Tokyo

TEL

0422-47-5511

Email

vas-mhlw@ks.kyorin-u.ac.jp


Public contact

Name of contact person

1st name Ken-ei
Middle name
Last name Sada

Organization

Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences

Division name

Department of Medicine and Clinical Science

Zip code

1818611

Address

2-5-1 Shikata-cho, Kita-ku, Okayama

TEL

086-235-7235

Homepage URL


Email

sadakenn@md.okayama-u.ac.jp


Sponsor or person

Institute

the Research Committee on Intractable Vasculitides, the Ministry of Health, Labour and Welfare of Japan

Institute

Department

Personal name



Funding Source

Organization

The Ministry of Health, Labor and Welfare of Japan

Organization

Division

Category of Funding Organization

Japanese Governmental office

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Faculty of Medicine Research Ethics Committee, Kyorin University

Address

6-20-2, Shinkawa, Mitaka, Tokyo 181-8611, Japan

Tel

0422-47-5514

Email

rec@ks.kyorin-u.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2014 Year 09 Month 17 Day


Related information

URL releasing protocol

https://upload.umin.ac.jp/cgi-open-bin/ctr/ctr.cgi?function=brows&action=brows&type=summary&language

Publication of results

Unpublished


Result

URL related to results and publications

http://mhlw-grants.niph.go.jp/niph/search/NIDD00.do?resrchNum=201610012A

Number of participants that the trial has enrolled

123

Results

Under data cleaning

Results date posted

2019 Year 03 Month 23 Day

Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics

Under data cleaning

Participant flow

Under data cleaning

Adverse events

Under data cleaning

Outcome measures

Under data cleaning

Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2014 Year 09 Month 08 Day

Date of IRB

2014 Year 09 Month 29 Day

Anticipated trial start date

2014 Year 09 Month 29 Day

Last follow-up date

2017 Year 12 Month 31 Day

Date of closure to data entry

2018 Year 01 Month 31 Day

Date trial data considered complete

2018 Year 03 Month 31 Day

Date analysis concluded

2018 Year 09 Month 30 Day


Other

Other related information

Medical data on each patient are collected to clarify the safety and efficacy of remission maintenance therapy in Japanese patients with ANCA-associated vasculitis.


Management information

Registered date

2014 Year 09 Month 17 Day

Last modified on

2020 Year 03 Month 23 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000017107


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name